Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings

Adams, 2000, Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum, J. Neurochem., 75, 2061, 10.1046/j.1471-4159.2000.0752061.x

Adams, 2003, Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix, J. Neurochem., 84, 87, 10.1046/j.1471-4159.2003.01507.x

Alburges, 2001, Unique responses of limbic met-enkephalin systems to low and high doses of methamphetamine, Brain Res., 905, 120, 10.1016/S0006-8993(01)02514-8

Alicata, 2009, Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users, Psychiatry Res., 174, 1, 10.1016/j.pscychresns.2009.03.011

Anglin, 2000, History of the methamphetamine problem, J. Psychoactive Drugs, 32, 137, 10.1080/02791072.2000.10400221

Armstrong, 2004, The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats, Neurotoxicology, 25, 905, 10.1016/j.neuro.2004.06.003

Barr, 2005, Psychostimulant withdrawal as an inducing condition in animal models of depression, Neurosci. Biobehav. Rev., 29, 675, 10.1016/j.neubiorev.2005.03.012

Barr, 1999, Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement, Psychopharmacology (Berl.), 141, 99, 10.1007/s002130050812

Barr, 2002, Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of d-amphetamine, Pharmacol. Biochem. Behav., 71, 293, 10.1016/S0091-3057(01)00664-5

Barr, 1999, Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat, Pharmacol. Biochem. Behav., 64, 597, 10.1016/S0091-3057(99)00156-2

Barr, 2000, Chronic corticosterone enhances the rewarding effect of hypothalamic self-stimulation in rats, Brain Res., 875, 196, 10.1016/S0006-8993(00)02652-4

Barr, 2002, Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor, Neuropsychopharmacology, 26, 286, 10.1016/S0893-133X(01)00308-6

Barr, 2002, A ‘crash’ course on psychostimulant withdrawal as a model of depression, Trends Pharmacol. Sci., 23, 475, 10.1016/S0165-6147(02)02086-2

Barr, 2002, Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats, Psychopharmacology (Berl.), 159, 196, 10.1007/s002130100906

Barr, 2006, The need for speed: an update on methamphetamine addiction, J. Psychiatry Neurosci., 31, 301

Belcher, 2005, Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity, Neuropsychopharmacology, 30, 2026, 10.1038/sj.npp.1300771

Berman, 2008, Abuse of amphetamines and structural abnormalities in the brain, Ann. N. Y. Acad. Sci., 1141, 195, 10.1196/annals.1441.031

Boileau, 2008, Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker?, J. Neurosci., 28, 9850, 10.1523/JNEUROSCI.3008-08.2008

Boyda, 2010, Preclinical models of antipsychotic drug-induced metabolic side effects, Trends Pharmacol. Sci., 31, 484, 10.1016/j.tips.2010.07.002

Brodie, 2005, Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction, Synapse, 55, 122, 10.1002/syn.20097

Brown, 2001, Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants, J. Pharmacol. Exp. Ther., 296, 762

Bruijnzeel, 2010, Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats, Psychopharmacology (Berl.), 212, 485, 10.1007/s00213-010-1970-0

Bunzow, 2001, Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor, Mol. Pharmacol., 60, 1181, 10.1124/mol.60.6.1181

Cadet, 2009, Molecular bases of methamphetamine-induced neurodegeneration, Int. Rev. Neurobiol., 88, 101, 10.1016/S0074-7742(09)88005-7

Callaghan, 2010, Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders, Mov. Disord., 25, 2333, 10.1002/mds.23263

Callaghan, 2012, Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs, Drug Alcohol Depend., 120, 35, 10.1016/j.drugalcdep.2011.06.013

Castel, 1994, Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat, Eur. J. Pharmacol., 262, 1, 10.1016/0014-2999(94)90021-3

Chang, 2002, Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users, Psychiatry Res., 114, 65, 10.1016/S0925-4927(02)00004-5

Chang, 2005, Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response, Biol. Psychiatry, 57, 967, 10.1016/j.biopsych.2005.01.039

Chang, 2005, Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities, Am. J. Psychiatry, 162, 361, 10.1176/appi.ajp.162.2.361

Chartoff, 2004, Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy, Brain Res., 1022, 71, 10.1016/j.brainres.2004.06.061

Cheng, 2010, Binge use and sex and drug use behaviors among HIV(−), heterosexual methamphetamine users in San Diego, Subst. Use Misuse, 45, 116, 10.3109/10826080902869620

Cherner, 2010, Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults, Drug Alcohol Depend., 106, 154, 10.1016/j.drugalcdep.2009.08.010

Chung, 2007, Decreased frontal white-matter integrity in abstinent methamphetamine abusers, Int. J. Neuropsychopharmacol., 10, 765, 10.1017/S1461145706007395

Colfax, 2011, Mirtazapine to reduce methamphetamine use: a randomized controlled trial, Arch. Gen. Psychiatry, 68, 1168, 10.1001/archgenpsychiatry.2011.124

Commins, 1986, Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex, Brain Res., 365, 15, 10.1016/0006-8993(86)90717-1

Cook, 1990, Plasma levels of methamphetamine after smoking of methamphetamine hydrochloride, NIDA Res. Monogr., 105, 578

Cook, 1992, Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans, Drug Metab. Dispos., 20, 856

Cook, 1993, Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride, Drug Metab. Dispos., 21, 717

Cunningham, 2010, Proximity to the US–Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine and heroin purity, Addiction, 105, 1785, 10.1111/j.1360-0443.2010.03032.x

Darke, 2008, Major physical and psychological harms of methamphetamine use, Drug Alcohol Rev., 27, 253, 10.1080/09595230801923702

Daumann, 2011, Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry, Neuroimage, 54, 794, 10.1016/j.neuroimage.2010.08.065

De La Garza, 2009, The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers, Pharmacol. Biochem. Behav., 94, 186, 10.1016/j.pbb.2009.08.007

DEA, 2010, Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule, Fed. Regist., 75, 4973

Di Costanzo, 2007, Proton MR spectroscopy of the brain at 3T: an update, Eur. Radiol., 17, 1651, 10.1007/s00330-006-0546-1

Elkashef, 2008, Bupropion for the treatment of methamphetamine dependence, Neuropsychopharmacology, 33, 1162, 10.1038/sj.npp.1301481

Ende, 1997, Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging, Radiology, 202, 809, 10.1148/radiology.202.3.9051038

Ernst, 1997, Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy, Radiology, 203, 829, 10.1148/radiology.203.3.9169712

Ernst, 2000, Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study, Neurology, 54, 1344, 10.1212/WNL.54.6.1344

Farfel, 1995, Role of hypothermia in the mechanism of protection against serotonergic toxicity, II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan, J. Pharmacol. Exp. Ther., 272, 868

Fasano, 2008, Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding, Drug Alcohol Depend., 96, 178, 10.1016/j.drugalcdep.2008.02.005

Fleckenstein, 2007, New insights into the mechanism of action of amphetamines, Annu. Rev. Pharmacol. Toxicol., 47, 681, 10.1146/annurev.pharmtox.47.120505.105140

Fleckenstein, 2009, Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications, Neuropharmacology, 56, 133, 10.1016/j.neuropharm.2008.07.002

Floor, 1996, Amphetamine releases dopamine from synaptic vesicles by dual mechanisms, Neurosci. Lett., 215, 53, 10.1016/S0304-3940(96)12963-3

Fog, 2006, Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport, Neuron, 51, 417, 10.1016/j.neuron.2006.06.028

Frankel, 2007, Brain levels of neuropeptides in human chronic methamphetamine users, Neuropharmacology, 53, 447, 10.1016/j.neuropharm.2007.06.009

Frankel, 2008, Differential response of neurotensin to methamphetamine self-administration, Ann. N. Y. Acad. Sci., 1139, 112, 10.1196/annals.1432.019

Frankel, 2011, Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia, J. Pharmacol. Exp. Ther., 336, 809, 10.1124/jpet.110.176610

Fung, 1982, The differential effects of amphetamine and methylphenidate on the biosynthesis of [3H]dopa from [3H]tyrosine in mouse striata in vivo, J. Pharm. Pharmacol., 34, 531, 10.1111/j.2042-7158.1982.tb04783.x

Galloway, 2011, A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction, Clin. Pharmacol. Ther., 89, 276, 10.1038/clpt.2010.307

Glasner-Edwards, 2009, Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up, J. Nerv. Ment. Dis., 197, 225, 10.1097/NMD.0b013e31819db6fe

Gold, 2009, Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates, Biol. Psychiatry, 66, 118, 10.1016/j.biopsych.2009.02.021

Gonzales, 2009, Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period, J. Subst. Abuse Treat., 37, 353, 10.1016/j.jsat.2009.04.001

Gonzalez, 2004, Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure, Drug Alcohol Depend., 76, 181, 10.1016/j.drugalcdep.2004.04.014

Graves, 2011, Mirtazapine alters cue-associated methamphetamine seeking in rats, Biol. Psychiatry, 69, 275, 10.1016/j.biopsych.2010.09.032

Graves, 2012, SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats, BMC Neurosci., 13, 65, 10.1186/1471-2202-13-65

Gross, 2011, Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity, Synapse, 65, 1144, 10.1002/syn.20952

Gruenewald, 2010, Assessing correlates of the growth and extent of methamphetamine abuse and dependence in California, Subst. Use Misuse, 45, 1948, 10.3109/10826081003682867

Hadamitzky, 2011, Extended access to methamphetamine self-administration affects sensorimotor gating in rats, Behav. Brain Res., 217, 386, 10.1016/j.bbr.2010.11.009

Halkitis, 2009

Hamamoto, 2009, Methamphetamine abuse and dentistry, Oral Dis., 15, 27, 10.1111/j.1601-0825.2008.01459.x

Hanson, 2002, Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine, J. Neurochem., 82, 1171, 10.1046/j.1471-4159.2002.01053.x

Hanson, 2004, The methamphetamine experience: a NIDA partnership, Neuropharmacology, 47, 92, 10.1016/j.neuropharm.2004.06.004

Hanson, 2009, Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment, Eur. J. Pharmacol., 607, 68, 10.1016/j.ejphar.2009.01.037

Hanson, 2012, Response of limbic neurotensin systems to methamphetamine self-administration, Neuroscience, 203, 99, 10.1016/j.neuroscience.2011.12.037

Harris, 2003, The bioavailability of intranasal and smoked methamphetamine, Clin. Pharmacol. Ther., 74, 475, 10.1016/j.clpt.2003.08.002

Harris, 2003, Altering cortisol level does not change the pleasurable effects of methamphetamine in humans, Neuropsychopharmacology, 28, 1677, 10.1038/sj.npp.1300223

Hart, 2001, Methamphetamine self-administration by humans, Psychopharmacology (Berl.), 157, 75, 10.1007/s002130100738

Heinzerling, 2006, Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence, Drug Alcohol Depend., 85, 177, 10.1016/j.drugalcdep.2006.03.019

Heinzerling, 2010, Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence, Drug Alcohol Depend., 109, 20, 10.1016/j.drugalcdep.2009.11.023

Hogan, 2000, Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations, J. Neurochem., 74, 2217, 10.1046/j.1471-4159.2000.0742217.x

Hondebrink, 2009, Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure, J. Neurochem., 111, 624, 10.1111/j.1471-4159.2009.06357.x

Iudicello, 2010, Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence, J. Clin. Exp. Neuropsychol., 32, 704, 10.1080/13803390903512637

Iwanami, 1994, Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report, Acta Psychiatr. Scand., 89, 428, 10.1111/j.1600-0447.1994.tb01541.x

Iyo, 1997, Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT, Prog. Neuropsychopharmacol. Biol. Psychiatry, 21, 789, 10.1016/S0278-5846(97)00079-1

Iyo, 2004, Neuromechanism of developing methamphetamine psychosis: a neuroimaging study, Ann. N. Y. Acad. Sci., 1025, 288, 10.1196/annals.1316.036

Jang, 2012, A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats, Psychopharmacology (Berl.)

Johanson, 2006, Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers, Psychopharmacology (Berl.), 185, 327, 10.1007/s00213-006-0330-6

Johnson, 1988, Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport, Physiol. Rev., 68, 232, 10.1152/physrev.1988.68.1.232

Johnson, 2007, Effects of acute topiramate dosing on methamphetamine-induced subjective mood, Int. J. Neuropsychopharmacol., 10, 85, 10.1017/S1461145705006401

Johnson, 2008, A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence, Int. J. Neuropsychopharmacol., 11, 1, 10.1017/S1461145707007778

Johnston, 2012

Kahlig, 2003, Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine, Eur. J. Pharmacol., 479, 153, 10.1016/j.ejphar.2003.08.065

Kahlig, 2005, Amphetamine induces dopamine efflux through a dopamine transporter channel, Proc. Natl. Acad. Sci. U. S. A., 102, 3495, 10.1073/pnas.0407737102

Kalechstein, 2003, Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence, J. Neuropsychiatry Clin. Neurosci., 15, 215, 10.1176/appi.neuropsych.15.2.215

Kaushal, 2012, Pharmacological evaluation of SN79, a sigma (sigma) receptor ligand, against methamphetamine-induced neurotoxicity in vivo, Eur. Neuropsychopharmacol., 10.1016/j.euroneuro.2012.08.005

Kerr, 2005, High rates of primary care and emergency department use among injection drug users in Vancouver, J. Public Health (Oxf.), 27, 62, 10.1093/pubmed/fdh189

Kim, 2009, Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts, Neurotoxicology, 30, 209, 10.1016/j.neuro.2008.12.002

King, 2010, Neuropsychological deficits in adolescent methamphetamine abusers, Psychopharmacology (Berl.), 212, 243, 10.1007/s00213-010-1949-x

King, 2010, Psychiatric symptoms and HPA axis function in adolescent methamphetamine users, J. Neuroimmune Pharmacol., 5, 582, 10.1007/s11481-010-9206-y

Kish, 2008, Pharmacologic mechanisms of crystal meth, CMAJ, 178, 1679, 10.1503/cmaj.071675

Kiyatkin, 2007, Brain edema and breakdown of the blood–brain barrier during methamphetamine intoxication: critical role of brain hyperthermia, Eur. J. Neurosci., 26, 1242, 10.1111/j.1460-9568.2007.05741.x

Kobeissy, 2012, Methods in drug abuse models: comparison of different models of methamphetamine paradigms, Methods Mol. Biol., 829, 269, 10.1007/978-1-61779-458-2_17

Koob, 2010, Neurocircuitry of addiction, Neuropsychopharmacology, 35, 217, 10.1038/npp.2009.110

Krasnova, 2009, Methamphetamine toxicity and messengers of death, Brain Res. Rev., 60, 379, 10.1016/j.brainresrev.2009.03.002

Krasnova, 2010, Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat, PLoS ONE, 5, e8790, 10.1371/journal.pone.0008790

Kuczenski, 1975, Differential effects of d- and l-amphetamine and methylphenidate on rat striatal dopamine biosynthesis, Eur. J. Pharmacol., 30, 244, 10.1016/0014-2999(75)90106-5

Laqueille, 2005, Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder, Eur. Psychiatry, 20, 456, 10.1016/j.eurpsy.2005.03.013

Leamon, 2010, Methamphetamine and paranoia: the methamphetamine experience questionnaire, Am. J. Addict., 19, 155, 10.1111/j.1521-0391.2009.00014.x

Lecomte, 2010, Profiles of individuals seeking psychiatric help for psychotic symptoms linked to methamphetamine abuse – baseline results from the MAPS (methamphetamine and psychosis study), Mental Health Subst. Use, 3, 168, 10.1080/17523281.2010.504645

Lee, 2008, A systematic review of cognitive and behavioural therapies for methamphetamine dependence, Drug Alcohol Rev., 27, 309, 10.1080/09595230801919494

Lee, 2009, Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity, J. Neurosci., 29, 14734, 10.1523/JNEUROSCI.3765-09.2009

Leung, 2012, Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system, Pharmacol. Ther., 135, 113, 10.1016/j.pharmthera.2012.04.003

Li, 2010, Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine, J. Neurochem., 114, 873, 10.1111/j.1471-4159.2010.06818.x

Lile, 2005, Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans, Neuropsychopharmacology, 30, 2103, 10.1038/sj.npp.1300803

Loftis, 2010, Methamphetamine causes persistent immune dysregulation: a cross-species, translational report, Neurotox. Res., 20, 59, 10.1007/s12640-010-9223-x

Lominac, 2012, Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine, Neuropsychopharmacology, 37, 707, 10.1038/npp.2011.248

London, 2004, Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers, Arch. Gen. Psychiatry, 61, 73, 10.1001/archpsyc.61.1.73

Longo, 2010, Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence, Addiction, 105, 146, 10.1111/j.1360-0443.2009.02717.x

Lute, 2008, PI3K signaling supports amphetamine-induced dopamine efflux, Biochem. Biophys. Res. Commun., 372, 656, 10.1016/j.bbrc.2008.05.091

Mack, 1979, Dissociation constants and lipophilicity of catecholamines and related compounds, Naunyn-Schmiedeberg's Arch. Pharmacol., 310, 1, 10.1007/BF00499868

Mahoney, 2011, Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline, Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 459, 10.1016/j.pnpbp.2010.11.034

Mahoney, 2012, Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers, Int. J. Neuropsychopharmacol., 15, 1241, 10.1017/S1461145711001805

Mark, 2004, High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity, J. Neurosci., 24, 11449, 10.1523/JNEUROSCI.3597-04.2004

Maxwell, 2008, The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992–2007, Drug Alcohol Rev., 27, 229, 10.1080/09595230801919460

McCann, 1998, Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428, J. Neurosci., 18, 8417, 10.1523/JNEUROSCI.18-20-08417.1998

McCann, 2008, Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users, Synapse, 62, 91, 10.1002/syn.20471

McEwen, 2010, Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease, Ann. N. Y. Acad. Sci., 1186, 190, 10.1111/j.1749-6632.2009.05331.x

McFadden, 2012, Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure, J. Pharmacol. Exp. Ther., 340, 295, 10.1124/jpet.111.188433

McFadden, 2012, Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations, Drug Alcohol Depend., 126, 87, 10.1016/j.drugalcdep.2012.04.020

McKetin, 2010, The risk of psychotic symptoms associated with recreational methamphetamine use, Drug Alcohol Rev., 29, 358, 10.1111/j.1465-3362.2009.00160.x

Mehrjerdi, 2012, Attention deficits in chronic methamphetamine users as a potential target for enhancing treatment efficacy, Basic Clin. Neurosci., 3, 5

Meijler, 2004, Development of immunopharmacotherapy against drugs of abuse, Curr. Drug Discov. Technol., 1, 77, 10.2174/1570163043484851

Misawa, 2011, Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? A cross-sectional study, BMC Psychiatry, 11, 118, 10.1186/1471-244X-11-118

Misra, 1997, Risperidone treatment of methamphetamine psychosis, Am. J. Psychiatry, 154, 1170, 10.1176/ajp.154.8.1170a

Misra, 2000, Olanzapine treatment of methamphetamine psychosis, J. Clin. Psychopharmacol., 20, 393, 10.1097/00004714-200006000-00023

Moszczynska, 2004, Why is parkinsonism not a feature of human methamphetamine users?, Brain, 127, 363, 10.1093/brain/awh046

Narita, 2004, Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats, Neuroscience, 127, 941, 10.1016/j.neuroscience.2004.06.017

Nejtek, 2008, Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial, J. Clin. Psychiatry, 69, 1257, 10.4088/JCP.v69n0808

Newton, 2006, Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving, Neuropsychopharmacology, 31, 1537, 10.1038/sj.npp.1300979

Newton, 2008, Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers, Int. J. Neuropsychopharmacol., 11, 1037, 10.1017/S1461145708009097

Nordahl, 2003, Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review, J. Neuropsychiatry Clin. Neurosci., 15, 317, 10.1176/appi.neuropsych.15.3.317

Nordahl, 2005, Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study, Arch. Gen. Psychiatry, 62, 444, 10.1001/archpsyc.62.4.444

Northrop, 2011, Regulation of glutamate release by alpha7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals, J. Pharmacol. Exp. Ther., 336, 900, 10.1124/jpet.110.177287

Oh, 2005, Shape changes of the corpus callosum in abstinent methamphetamine users, Neurosci. Lett., 384, 76, 10.1016/j.neulet.2005.04.082

O’Neil, 2006, Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge, Synapse, 60, 465, 10.1002/syn.20320

Payer, 2011, Neural correlates of affect processing and aggression in methamphetamine dependence, Arch. Gen. Psychiatry, 68, 271, 10.1001/archgenpsychiatry.2010.154

Pontieri, 1990, Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats, Psychopharmacology (Berl.), 102, 175, 10.1007/BF02245919

Procyshyn, 2007, Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment, J. Psychiatry Neurosci., 32, 331

Procyshyn, 2010, Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients, J. Clin. Psychiatry, 71, 566, 10.4088/JCP.08m04912gre

Qi, 2009, Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement, Neuropharmacology, 56, 856, 10.1016/j.neuropharm.2009.01.010

Rawson, 2002, Will the methamphetamine problem go away?, J. Addict. Dis., 21, 5, 10.1300/J069v21n01_02

Rawson, 2004, A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence, Addiction, 99, 708, 10.1111/j.1360-0443.2004.00707.x

Reese, 2007, Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine, J. Pharmacol. Exp. Ther., 321, 178, 10.1124/jpet.106.115402

Reichel, 2012, Methamphetamine-induced changes in the object recognition memory circuit, Neuropharmacology, 62, 1119, 10.1016/j.neuropharm.2011.11.003

Revel, 2012, Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics, Biol. Psychiatry, 72, 934, 10.1016/j.biopsych.2012.05.014

Rhodus, 2008, Methamphetamine abuse and “meth mouth.”, PA Dent. J. (Harrisb.), 75, 19

Ricaurte, 1984, Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers, Brain Res., 303, 359, 10.1016/0006-8993(84)91221-6

Riddle, 2002, Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine, Eur. J. Pharmacol., 449, 71, 10.1016/S0014-2999(02)01985-4

Riddle, 2006, Mechanisms of methamphetamine-induced dopaminergic neurotoxicity, AAPS J., 8, E413, 10.1007/BF02854914

Rippeth, 2004, Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons, J. Int. Neuropsychol. Soc., 10, 1, 10.1017/S1355617704101021

Robinson, 1985, Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl, Biochem. Pharmacol., 34, 4105, 10.1016/0006-2952(85)90201-1

Rose, 2008, Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions, Ann. Clin. Psychiatry, 20, 145, 10.1080/10401230802177656

Rothman, 2001, Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin, Synapse, 39, 32, 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3

Rusyniak, 2011, Neurologic manifestations of chronic methamphetamine abuse, Neurol. Clin., 29, 641, 10.1016/j.ncl.2011.05.004

Salo, 2002, Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals, Psychiatry Res., 111, 65, 10.1016/S0165-1781(02)00111-7

Salo, 2007, Attentional control and brain metabolite levels in methamphetamine abusers, Biol. Psychiatry, 61, 1272, 10.1016/j.biopsych.2006.07.031

Salo, 2009, Drug abstinence and cognitive control in methamphetamine-dependent individuals, J. Subst. Abuse Treat., 37, 292, 10.1016/j.jsat.2009.03.004

Salo, 2011, Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study, Drug Alcohol Depend., 113, 133, 10.1016/j.drugalcdep.2010.07.015

Saunders, 2000, Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism, Proc. Natl. Acad. Sci. U. S. A., 97, 6850, 10.1073/pnas.110035297

Schmitt, 2010, Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse, Ann. N. Y. Acad. Sci., 1187, 316, 10.1111/j.1749-6632.2009.05148.x

Schneider, 1972, Amphetamine-induced exocytosis of catecholamines from the cow adrenal medulla, J. Pharmacol. Exp. Ther., 183, 80

Schuldiner, 1994, A molecular glimpse of vesicular monoamine transporters, J. Neurochem., 62, 2067, 10.1046/j.1471-4159.1994.62062067.x

Schwartz, 2006, The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles, J. Neural Transm., 113, 1347, 10.1007/s00702-005-0383-4

Scott, 2007, Neurocognitive effects of methamphetamine: a critical review and meta-analysis, Neuropsychol. Rev., 17, 275, 10.1007/s11065-007-9031-0

Segal, 1999, Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses, Psychopharmacology (Berl.), 142, 182, 10.1007/s002130050878

Segal, 2006, Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance, Neuropsychopharmacology, 31, 941, 10.1038/sj.npp.1300865

Sekine, 2001, Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET, Am. J. Psychiatry, 158, 1206, 10.1176/appi.ajp.158.8.1206

Sekine, 2002, Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study, Neuropsychopharmacology, 27, 453, 10.1016/S0893-133X(02)00321-4

Sekine, 2006, Brain serotonin transporter density and aggression in abstinent methamphetamine abusers, Arch. Gen. Psychiatry, 63, 90, 10.1001/archpsyc.63.1.90

Shearer, 2001, Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence, Addiction, 96, 1289, 10.1046/j.1360-0443.2001.96912898.x

Shoblock, 2003, Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats, Psychopharmacology (Berl.), 165, 359, 10.1007/s00213-002-1288-7

Shoptaw, 2008, Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence, Drug Alcohol Depend., 96, 222, 10.1016/j.drugalcdep.2008.03.010

Simon, 2000, Cognitive impairment in individuals currently using methamphetamine, Am. J. Addict., 9, 222, 10.1080/10550490050148053

Smith, 1998, Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels, J. Biol. Chem., 273, 23321, 10.1074/jbc.273.36.23321

Stoops, 2006, A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine, Drug Alcohol Depend., 84, 206, 10.1016/j.drugalcdep.2006.02.004

Sulzer, 1990, Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action, Neuron, 5, 797, 10.1016/0896-6273(90)90339-H

Sulzer, 1993, Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons, J. Neurochem., 60, 527, 10.1111/j.1471-4159.1993.tb03181.x

Sulzer, 2005, Mechanisms of neurotransmitter release by amphetamines: a review, Prog. Neurobiol., 75, 406, 10.1016/j.pneurobio.2005.04.003

Talloczy, 2008, Methamphetamine inhibits antigen processing, presentation, and phagocytosis, PLoS Pathog., 4, e28, 10.1371/journal.ppat.0040028

Tata, 2007, Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia, Eur. J. Neurosci., 26, 739, 10.1111/j.1460-9568.2007.05688.x

Tedeschi, 1996, Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging, Neurology, 47, 696, 10.1212/WNL.47.3.696

Thompson, 2004, Structural abnormalities in the brains of human subjects who use methamphetamine, J. Neurosci., 24, 6028, 10.1523/JNEUROSCI.0713-04.2004

Tiihonen, 2007, A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence, Am. J. Psychiatry, 164, 160, 10.1176/appi.ajp.164.1.160

Tobias, 2010, White-matter abnormalities in brain during early abstinence from methamphetamine abuse, Psychopharmacology (Berl.), 209, 13, 10.1007/s00213-009-1761-7

Tong, 2003, Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users, Am. J. Psychiatry, 160, 896, 10.1176/appi.ajp.160.5.896

Tsukada, 1999, Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys, Brain Res., 841, 160, 10.1016/S0006-8993(99)01834-X

Tulloch, 2011, A single high dose of methamphetamine induces apoptotic and necrotic striatal cell loss lasting up to 3 months in mice, Neuroscience, 193, 162, 10.1016/j.neuroscience.2011.07.020

United Nations Office on Drugs and Crime World Drug Report, 2008. United Nations Publication Sales No. E08XI1. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2008.html.

van der Plas, 2009, Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women, J. Clin. Exp. Neuropsychol., 31, 706, 10.1080/13803390802484797

Volkow, 2001, Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence, J. Neurosci., 21, 9414, 10.1523/JNEUROSCI.21-23-09414.2001

Volkow, 2001, Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers, Am. J. Psychiatry, 158, 383, 10.1176/appi.ajp.158.3.383

Volkow, 2001, Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers, Am. J. Psychiatry, 158, 377, 10.1176/appi.ajp.158.3.377

Wachtel, 2002, The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers, Drug Alcohol Depend., 68, 23, 10.1016/S0376-8716(02)00104-7

Wang, 2004, Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence, Am. J. Psychiatry, 161, 242, 10.1176/appi.ajp.161.2.242

Weiland-Fiedler, 2004, Evidence for continuing neuropsychological impairments in depression, J. Affect. Disord., 82, 253, 10.1016/j.jad.2003.10.009

Werb, 2010, Methamphetamine use and malnutrition among street-involved youth, Harm Reduct. J., 7, 5, 10.1186/1477-7517-7-5

Wilson, 1996, Striatal dopamine nerve terminal markers in human, chronic methamphetamine users, Nat. Med., 2, 699, 10.1038/nm0696-699

Woods, 2005, Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence, Neuropsychology, 19, 35, 10.1037/0894-4105.19.1.35

Xie, 2009, A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain, J. Pharmacol. Exp. Ther., 330, 316, 10.1124/jpet.109.153775

Zorick, 2010, Withdrawal symptoms in abstinent methamphetamine-dependent subjects, Addiction, 105, 1809, 10.1111/j.1360-0443.2010.03066.x